A CITF-funded study published in AIDS and led by Drs. Aslam Anis (University of British Columbia) and Ann Burchell (University of Toronto) on behalf of the COVAXHIV study team, highlighted that – prior to Omicron – two doses of COVID-19 vaccines offered substantial protection against hospitalization and death, and even symptomatic illness,  in people living with HIV (PLWH).